A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar.

This comes after both Maccabi and Meuhedet Health Services announced the same subsidy for the Mounjaro weight loss shot.

The startup, which has already raised more than half a billion dollars, released Phase 2 results that could position its drug ...

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...

Experimental weight-loss drug Retatrutide shows promise, helping obese adults lose up to 22% of their weight in 48 weeks.

Dr. Ashish Jha, the dean of Brown University's School of Public Health and former White House COVID-19 response coordinator, ...

Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...

Millions of people have used Ozempic and similar drugs to lose weight, but are unhappy with the way their faces change, leading some to turn to a non-surgical treatment to flesh out their cheeks again ...